pre-IPO PHARMA

COMPANY OVERVIEW

Ensysce Biosciences, San Diego CA, is an integrated drug delivery company for both small and large molecules. The BIO-MD™ prodrug abuse deterrent and MPAR™ overdose resistant pain platforms of Ensysce eliminate the ability to abuse opioid products by the non-oral route, something that is the fastest growing drug problem in the US and that leads to billions in healthcare costs annually.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Pain

  • WEBSITE

    https://www.ensysce.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Dec 31, 2020

    Ensysce Biosciences, a California Based Biotech With a Mission to Solve the Opioid Crisis, Secures $60 Million Capital Commitment From Global Emerging Markets


    Sep 28, 2020

    COVISTAT, a Subsidiary of Ensysce Biosciences Inc, a California Based Company With a Mission to Solve the Opioid Crisis, Is Commencing Phase 1 Study of Novel COVID-19 Treatment


    Sep 8, 2020

    Ensysce Biosciences, a California Based Biotech With a Mission to Solve the Opioid Crisis, Announces Steven R. Martin to Join Board of Directors


    Dec 12, 2019

    Ensysce Biosciences Andrew Benton to Join Board of Directors


    Sep 26, 2019

    Ensysce Biosciences Receives Multi-Year NIH HEAL Grant to Develop a Novel Opioid-Use-Disorder (OUD) Medication


    For More Press Releases


    Google Analytics Alternative